BMJ9h
The natural history of acute myocardial infarction
Dr RM Norris, Royal Sussex County Hospital, Eastern Road, Brighton, East Sussex BN2 5BE, UK If you wish to reuse any or all of this article please use the link below ...
BMJ11h
The master’s legacy: the first Paul Wood lecture
Grown-Up Congenital Heart Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK If you wish to reuse any or all of this article please use the link below ...
BMJ8d
Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches
Secondary mitral regurgitation (SMR) is a complex and evolving challenge in the landscape of heart failure (HF) management. Although significant secondary MR has been widely recognised for its adverse ...
BMJ8d
Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study
Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). This study aimed to evaluate the temporal relationship between ...
BMJ21h
Understanding coronary artery disease: tomographic imaging with intravascular ultrasound
In 1856 the pathologist Virchow published his now classic observations on atherothrombosis based on the examination of postmortem tomographic artery sections. The Virchow triad describes three ...
BMJ4d
Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction
King's College London BHF Centre of Excellence, Department of Cardiology, King's College Hospital, London, UK Correspondence to Dr Philip MacCarthy, Consultant Cardiologist, Department of Cardiology, ...
BMJ11d
Excessive daytime sleepiness: an emerging marker of cardiovascular risk
Excessive daytime sleepiness (EDS) is classically viewed as a consequence of insufficient sleep or a symptom of sleep disorders. Epidemiological and clinical evidence have shown that patients ...
BMJ13d
Change in renal function associated with drug treatment in heart failure: national guidance
Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS ...
BMJ4d
Mental disorders and cardiovascular disease: what should we be looking out for?
Correspondence to Dr Matthias Michal, Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany; ...
BMJ10d
Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial
Background To determine whether granulocyte colony-stimulating factor (G-CSF) improves clinical outcomes after large ST-elevation myocardial infarction (STEMI) when administered early in patients with ...
BMJ5d
Percutaneous coronary intervention for stable coronary artery disease
The adverse consequences of stable coronary artery disease (CAD) are death, myocardial infarction (MI) and angina. Trials in stable CAD show that percutaneous coronary intervention (PCI) does not ...
BMJ13d
Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care
Objective Decreased kidney function increases cardiovascular risk and predicts poor survival. Estimated glomerular filtration rate (eGFR) by creatinine may theoretically be less accurate in the ...